StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

ENDRA Life Sciences's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 289.4% from the year before. The highest annual figure on record is 19M in fiscal 2020.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+289.4%
FY2024Dec 31, 20240M+5458.5%
FY2023Dec 31, 20230M-100.0%
FY2020Dec 31, 202019M+155.9%
FY2019Dec 31, 20197M+66.5%
FY2018Dec 31, 20185M+63.4%
FY2017Dec 31, 20173M+281.2%
FY2016Dec 31, 20161M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262M+245.2%
Q1 FY2026Mar 31, 20261M+115.1%
Q4 FY2025Dec 31, 20251M+349.9%
Q3 FY2025Sep 30, 20251M-98.2%
Q2 FY2025Jun 30, 20251M-98.3%
Q1 FY2025Mar 31, 20251M-98.7%
Q3 FY2024Sep 30, 20240M-99.3%
Q1 FY2022Mar 31, 202243M+80.2%
Q3 FY2021Sep 30, 202142M+184.4%
Q2 FY2021Jun 30, 202142M+262.1%
Q1 FY2021Mar 31, 202138M+388.9%
Q3 FY2020Sep 30, 202024M+221.6%
Q2 FY2020Jun 30, 202015M+98.5%
Q1 FY2020Mar 31, 202012M+55.1%
Q4 FY2019Dec 31, 20198M+23.7%
Q3 FY2019Sep 30, 20197M+89.1%
Q2 FY2019Jun 30, 20197M+89.2%
Q1 FY2019Mar 31, 20197M+89.2%
Q4 FY2018Dec 31, 20186M+59.1%
Q3 FY2018Sep 30, 20184M+0.5%
Q2 FY2018Jun 30, 20184M+61.0%
Q1 FY2018Mar 31, 20184M+442.4%
Q4 FY2017Dec 31, 20174M+442.7%
Q3 FY2017Sep 30, 20174M+440.1%
Q2 FY2017Jun 30, 20172M–
Q1 FY2017Mar 31, 20171M–
Q4 FY2016Dec 31, 20161M–
Q3 FY2016Sep 30, 20161M–

More ENDRA Life Sciences figures

See a number that looks wrong?